Armistice Capital »

Brookfield Corp Cl A Ltd Vt Sh shares owned by Armistice Capital

Quarter-by-quarter ownership of Brookfield Corp Cl A Ltd Vt Sh (BN) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Brookfield Corp Cl A Ltd Vt Sh

Tip: Access up to 7 years of quarterly data

All positions including Brookfield Corp Cl A Ltd Vt Sh held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Brookfield Corp Cl A Ltd Vt Sh by Armistice Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $236k 5.7k 41.54
2024-03-31 $715k 17k 41.87

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ptc Therapeutics I (PTCT)
Cytokinetics Com New (CYTK)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Immunovant (IMVT)
Agios Pharmaceuticals (AGIO)
Argenx Se Sponsored Adr (ARGX)
Novo-nordisk A S Adr (NVO)
Sanofi Sponsored Adr (SNY)
Alkermes SHS (ALKS)
Medtronic SHS (MDT)
Aurinia Pharmaceuticals (AUPH)

View all positions for Armistice Capital

Top funds holding Brookfield Corp Cl A Ltd Vt Sh

Partners Value Investments
Royal Bank of Canada
Principal Financial Group
Vanguard Group
Capital World Investors
Brookfield Asset Management
Pershing Square Capital Management
TD Asset Management
Goodman & Company, Investment Counsel
Jarislowsky, Fraser
Akre Capital Management
First Manhattan
Mackenzie Financial
Bank of Nova Scotia
CIBC Global Asset Management

View all funds holding Brookfield Corp Cl A Ltd Vt Sh